Macquarie set a $24.00 target price on Keurig Dr Pepper (NYSE:KDP) in a research report sent to investors on Friday morning. The brokerage currently has a hold rating on the stock.

Several other research analysts have also recently issued reports on KDP. ValuEngine raised Keurig Dr Pepper from a sell rating to a hold rating in a research note on Tuesday, October 2nd. Goldman Sachs Group began coverage on Keurig Dr Pepper in a research note on Wednesday, July 18th. They issued a neutral rating and a $26.00 price objective on the stock. Stifel Nicolaus began coverage on Keurig Dr Pepper in a research note on Wednesday, July 11th. They issued a hold rating and a $20.00 price objective on the stock. Bank of America set a $30.00 price objective on Keurig Dr Pepper and gave the stock a buy rating in a research note on Monday, July 16th. Finally, Susquehanna Bancshares began coverage on Keurig Dr Pepper in a research note on Wednesday, July 25th. They issued a positive rating and a $33.00 price objective on the stock. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of $25.38.

Shares of KDP traded up $0.25 during mid-day trading on Friday, reaching $23.04. 3,044,758 shares of the company’s stock traded hands, compared to its average volume of 2,892,750. The stock has a market cap of $32.18 billion, a price-to-earnings ratio of 5.07, a P/E/G ratio of 1.33 and a beta of 0.74. Keurig Dr Pepper has a 12 month low of $20.46 and a 12 month high of $126.65. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.75 and a current ratio of 0.93.

Keurig Dr Pepper (NYSE:KDP) last announced its quarterly earnings data on Wednesday, August 8th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $1.01. Keurig Dr Pepper had a return on equity of 39.52% and a net margin of 15.98%. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $2.85 billion. The company’s revenue for the quarter was up 5.0% on a year-over-year basis. As a group, analysts predict that Keurig Dr Pepper will post 1.05 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 19th. Shareholders of record on Friday, October 5th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, October 4th. This represents a $0.60 annualized dividend and a yield of 2.60%. Keurig Dr Pepper’s dividend payout ratio (DPR) is presently 13.22%.

In related news, insider Maria A. Sceppaguercio-Gever bought 42,498 shares of the company’s stock in a transaction on Wednesday, August 15th. The shares were acquired at an average price of $23.53 per share, with a total value of $999,977.94. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Robert S. Singer bought 10,000 shares of the company’s stock in a transaction on Friday, August 10th. The shares were bought at an average cost of $23.75 per share, for a total transaction of $237,500.00. The disclosure for this purchase can be found here. Insiders have acquired a total of 185,270 shares of company stock worth $4,338,850 in the last ninety days. Insiders own 0.58% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in KDP. Bank of Montreal Can purchased a new stake in shares of Keurig Dr Pepper during the 3rd quarter valued at $1,699,000. Wendell David Associates Inc. purchased a new stake in shares of Keurig Dr Pepper during the 3rd quarter valued at $213,000. State of Alaska Department of Revenue purchased a new stake in shares of Keurig Dr Pepper during the 3rd quarter valued at $17,663,000. Cerebellum GP LLC purchased a new stake in shares of Keurig Dr Pepper during the 3rd quarter valued at $188,000. Finally, Bath Savings Trust Co purchased a new stake in shares of Keurig Dr Pepper during the 3rd quarter valued at $409,000. 11.55% of the stock is currently owned by institutional investors and hedge funds.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.

Featured Article: What do I need to know about analyst ratings?

Analyst Recommendations for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.